DrugDashboards

Maximum Strength Guaifenesin DM

Guaifenesin, Dextromethorphan HBr · DEXTROMETHORPHAN HYDROBROMIDE 60 mg/1; GUAIFENESIN 1200 mg/1 · Tablet, Extended Release · Oral · Rugby Laboratories

NDC 00536-1213-88 · 14 BLISTER PACK in 1 CARTON / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · ANDA · View full market →

The short version

8 companies supply this market — a reasonable cushion if one runs into trouble. The price has held steady around $0.5459 per unit over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.25$0.5$0.75Jan 2019Sep 2026$0.5459
90 price points · per EASource: CMS NADAC

Estimated fill cost

#30 count
$16.38
#90 count
$49.13

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$92,195
4,641 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for guaifenesin and dextromethorphan hbr (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA209692
TE code
Approval date
Nov 1, 2018
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Guaifenesin, Dextromethorphan HBr (Tablet, Extended Release)

LabelerStrengthFirst seenLast seen
H E BDEXTROMETHORPHAN HYDROBROMIDE 60 mg/1; GUAIFENESIN 1200 mg/1Jul 15, 2026Sep 3, 2026
Atlantic Biologicals Corp.GUAIFENESIN 600 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 30 mg/1Aug 26, 2026Sep 2, 2026
CVS PharmacyGUAIFENESIN 1200 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 60 mg/1Aug 26, 2026Sep 2, 2026
FSA Store Inc. (Caring Mills)DEXTROMETHORPHAN HYDROBROMIDE 60 mg/1; GUAIFENESIN 1200 mg/1Jul 15, 2026Sep 2, 2026
H E BGUAIFENESIN 600 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 30 mg/1Aug 26, 2026Sep 2, 2026
Rugby LaboratoriesDEXTROMETHORPHAN HYDROBROMIDE 60 mg/1; GUAIFENESIN 1200 mg/1Jul 15, 2026Sep 2, 2026
Rugby LaboratoriesGUAIFENESIN 600 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 30 mg/1Aug 26, 2026Sep 2, 2026
Strategic Sourcing Services LLCGUAIFENESIN 600 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 30 mg/1Aug 26, 2026Sep 2, 2026
Strategic Sourcing Services LLCDEXTROMETHORPHAN HYDROBROMIDE 60 mg/1; GUAIFENESIN 1200 mg/1Jul 15, 2026Sep 2, 2026
Yyba CorpDEXTROMETHORPHAN HYDROBROMIDE 60 mg/1; GUAIFENESIN 1200 mg/1Jul 15, 2026Sep 2, 2026
Family Dollar (FAMILY WELLNESS)DEXTROMETHORPHAN HYDROBROMIDE 60 mg/1; GUAIFENESIN 1200 mg/1Jul 15, 2026Aug 31, 2026
Atlantic Biologicals Corp.GUAIFENESIN 30 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 600 mg/1Jul 22, 2026Aug 19, 2026
CVS PharmacyGUAIFENESIN 60 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 1200 mg/1Jul 22, 2026Aug 19, 2026
H E BGUAIFENESIN 30 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 600 mg/1Jul 22, 2026Aug 19, 2026
Rugby LaboratoriesGUAIFENESIN 30 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 600 mg/1Jul 22, 2026Aug 19, 2026
Strategic Sourcing Services LLCGUAIFENESIN 30 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 600 mg/1Jul 22, 2026Aug 19, 2026
Atlantic Biologicals Corp.DEXTROMETHORPHAN HYDROBROMIDE 30 mg/1; GUAIFENESIN 600 mg/1Jul 15, 2026Jul 15, 2026
CVS PharmacyDEXTROMETHORPHAN HYDROBROMIDE 60 mg/1; GUAIFENESIN 1200 mg/1Jul 15, 2026Jul 15, 2026
H E BDEXTROMETHORPHAN HYDROBROMIDE 30 mg/1; GUAIFENESIN 600 mg/1Jul 15, 2026Jul 15, 2026
Rugby LaboratoriesDEXTROMETHORPHAN HYDROBROMIDE 30 mg/1; GUAIFENESIN 600 mg/1Jul 15, 2026Jul 15, 2026
Strategic Sourcing Services LLCDEXTROMETHORPHAN HYDROBROMIDE 30 mg/1; GUAIFENESIN 600 mg/1Jul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Maximum Strength Guaifenesin DM — NDC 00536-1213-88," retrieved September 3, 2026, https://drugdashboards.com/drug/00536121388.

Free to cite with attribution — see how the data is put together.